WhiteLab Genomics
Private Company
Unleash the Potential of Genomic Medicine Using AI
Biotechnology Research
Paris, Ile de France
11-50 employees
Founded 2019
About WhiteLab Genomics
Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines. By leveraging their proprietary technology, WhiteLab Genomics analyzes complex biological data powered by AI to significantly reduce development timelines and mitigate associated risks. Based on exhaustive datasets, the platform provides in-silico simulations to discover, and design optimized payloads and vectors.
Funding
Total Funding
$10.50M
No. of Funding Rounds
2
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos